Drak2 is not required for tumor surveillance and suppression

Drak2 is a promising therapeutic target to treat organ-specific autoimmune diseases such as type 1 diabetes and multiple sclerosis without causing generalized immune suppression. Inhibition of Drak2 may also prevent graft rejection following organ transplantation. However, Drak2 may function as a cr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Immunol
Main Authors: Edwards, Benjamin A., Harris, Tarsha L., Floersh, Helen, Lukens, John R., Zaki, Md. Hasan, Vogel, Peter, Kanneganti, Thirumala-Devi, Bui, Jack D., McGargill, Maureen A.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Short Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4817074/
https://ncbi.nlm.nih.gov/pubmed/25568303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/intimm/dxu146
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados